aluates Reports

$ 0.0

Automative

Global Biosimilar of Remicade Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-25X1659

Global Biosimilar of Remicade Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Biosimilar of Remicade Market Insights, Forecast to 2030

Code: QYRE-Auto-25X1659

Report

September 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi Aventis

Johnson & Johnson

Pfizer Inc

Novo Nordisk

Eli Lilly

Novartis

Merck

3SBio Inc

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Biosimilar of Remicade Market Size

The global Biosimilar of Remicade market is projected to grow from US$ 324000 million in 2024 to US$ 491720 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period.

Biosimilar of Remicade Market

A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and quality.

Market Analysis and Insights: Global Biosimilar of Remicade Market

The market for biosimilars of Remicade is driven by the increasing adoption of biosimilar therapies and the need for affordable treatment options for autoimmune diseases. The market's growth is also influenced by the presence of well-established regulatory pathways for biosimilar approval and the entry of multiple biosimilar manufacturers into the market.

Report Covers:

This report presents an overview of global market for Biosimilar of Remicade market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Biosimilar of Remicade, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biosimilar of Remicade, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biosimilar of Remicade revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biosimilar of Remicade market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biosimilar of Remicade revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Biosimilar of Remicade Market Report

Report Metric	Details
Report Name	Biosimilar of Remicade Market
Accounted market size in 2024	US$ 324000 million
Forecasted market size in 2030	US$ 491720 million
CAGR	7.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Monoclonal Antibodies Interferon Erythropoietin Insulin Vaccines Other
Segment by Application	Tumor Diabetes Cardiovascular Hemophilia Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biosimilar of Remicade in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar of Remicade companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilar of Remicade revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Biosimilar of Remicade Market growing?

Ans: The Biosimilar of Remicade Market witnessing a CAGR of 7.2 during the forecast period 2024-2030.

What is the Biosimilar of Remicade Market size in 2030?

Ans: The Biosimilar of Remicade Market size in 2030 will be US$ 491720 million.

Who are the main players in the Biosimilar of Remicade Market report?

Ans: The main players in the Biosimilar of Remicade Market are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories

What are the Application segmentation covered in the Biosimilar of Remicade Market report?

Ans: The Applications covered in the Biosimilar of Remicade Market report are Tumor, Diabetes, Cardiovascular, Hemophilia, Other

What are the Type segmentation covered in the Biosimilar of Remicade Market report?

Ans: The Types covered in the Biosimilar of Remicade Market report are Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other

Recommended Reports

Drug Delivery Systems

Biopharma Manufacturing

Autoimmune Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biosimilar of Remicade Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Interferon

1.2.4 Erythropoietin

1.2.5 Insulin

1.2.6 Vaccines

1.2.7 Other

1.3 Market by Application

1.3.1 Global Biosimilar of Remicade Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biosimilar of Remicade Market Perspective (2019-2030)

2.2 Global Biosimilar of Remicade Growth Trends by Region

2.2.1 Biosimilar of Remicade Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biosimilar of Remicade Historic Market Size by Region (2019-2024)

2.2.3 Biosimilar of Remicade Forecasted Market Size by Region (2025-2030)

2.3 Biosimilar of Remicade Market Dynamics

2.3.1 Biosimilar of Remicade Industry Trends

2.3.2 Biosimilar of Remicade Market Drivers

2.3.3 Biosimilar of Remicade Market Challenges

2.3.4 Biosimilar of Remicade Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Biosimilar of Remicade by Players

3.1.1 Global Biosimilar of Remicade Revenue by Players (2019-2024)

3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2019-2024)

3.2 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Biosimilar of Remicade, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Biosimilar of Remicade Market Concentration Ratio

3.4.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2023

3.5 Global Key Players of Biosimilar of Remicade Head office and Area Served

3.6 Global Key Players of Biosimilar of Remicade, Product and Application

3.7 Global Key Players of Biosimilar of Remicade, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar of Remicade Breakdown Data by Type

4.1 Global Biosimilar of Remicade Historic Market Size by Type (2019-2024)

4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2025-2030)

5 Biosimilar of Remicade Breakdown Data by Application

5.1 Global Biosimilar of Remicade Historic Market Size by Application (2019-2024)

5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biosimilar of Remicade Market Size (2019-2030)

6.2 North America Biosimilar of Remicade Market Size by Type

6.2.1 North America Biosimilar of Remicade Market Size by Type (2019-2024)

6.2.2 North America Biosimilar of Remicade Market Size by Type (2025-2030)

6.2.3 North America Biosimilar of Remicade Market Share by Type (2019-2030)

6.3 North America Biosimilar of Remicade Market Size by Application

6.3.1 North America Biosimilar of Remicade Market Size by Application (2019-2024)

6.3.2 North America Biosimilar of Remicade Market Size by Application (2025-2030)

6.3.3 North America Biosimilar of Remicade Market Share by Application (2019-2030)

6.4 North America Biosimilar of Remicade Market Size by Country

6.4.1 North America Biosimilar of Remicade Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Biosimilar of Remicade Market Size by Country (2019-2024)

6.4.3 North America Biosimilar of Remicade Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Biosimilar of Remicade Market Size (2019-2030)

7.2 Europe Biosimilar of Remicade Market Size by Type

7.2.1 Europe Biosimilar of Remicade Market Size by Type (2019-2024)

7.2.2 Europe Biosimilar of Remicade Market Size by Type (2025-2030)

7.2.3 Europe Biosimilar of Remicade Market Share by Type (2019-2030)

7.3 Europe Biosimilar of Remicade Market Size by Application

7.3.1 Europe Biosimilar of Remicade Market Size by Application (2019-2024)

7.3.2 Europe Biosimilar of Remicade Market Size by Application (2025-2030)

7.3.3 Europe Biosimilar of Remicade Market Share by Application (2019-2030)

7.4 Europe Biosimilar of Remicade Market Size by Country

7.4.1 Europe Biosimilar of Remicade Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Biosimilar of Remicade Market Size by Country (2019-2024)

7.4.3 Europe Biosimilar of Remicade Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Biosimilar of Remicade Market Size (2019-2030)

8.2 China Biosimilar of Remicade Market Size by Type

8.2.1 China Biosimilar of Remicade Market Size by Type (2019-2024)

8.2.2 China Biosimilar of Remicade Market Size by Type (2025-2030)

8.2.3 China Biosimilar of Remicade Market Share by Type (2019-2030)

8.3 China Biosimilar of Remicade Market Size by Application

8.3.1 China Biosimilar of Remicade Market Size by Application (2019-2024)

8.3.2 China Biosimilar of Remicade Market Size by Application (2025-2030)

8.3.3 China Biosimilar of Remicade Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Biosimilar of Remicade Market Size (2019-2030)

9.2 Asia Biosimilar of Remicade Market Size by Type

9.2.1 Asia Biosimilar of Remicade Market Size by Type (2019-2024)

9.2.2 Asia Biosimilar of Remicade Market Size by Type (2025-2030)

9.2.3 Asia Biosimilar of Remicade Market Share by Type (2019-2030)

9.3 Asia Biosimilar of Remicade Market Size by Application

9.3.1 Asia Biosimilar of Remicade Market Size by Application (2019-2024)

9.3.2 Asia Biosimilar of Remicade Market Size by Application (2025-2030)

9.3.3 Asia Biosimilar of Remicade Market Share by Application (2019-2030)

9.4 Asia Biosimilar of Remicade Market Size by Region

9.4.1 Asia Biosimilar of Remicade Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Biosimilar of Remicade Market Size by Region (2019-2024)

9.4.3 Asia Biosimilar of Remicade Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type

10.2.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application

10.3.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country

10.4.1 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Biosimilar of Remicade Introduction

11.1.4 Roche Revenue in Biosimilar of Remicade Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Biosimilar of Remicade Introduction

11.2.4 Amgen Revenue in Biosimilar of Remicade Business (2019-2024)

11.2.5 Amgen Recent Developments

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Biosimilar of Remicade Introduction

11.3.4 AbbVie Revenue in Biosimilar of Remicade Business (2019-2024)

11.3.5 AbbVie Recent Developments

11.4 Sanofi-Aventis

11.4.1 Sanofi-Aventis Company Details

11.4.2 Sanofi-Aventis Business Overview

11.4.3 Sanofi-Aventis Biosimilar of Remicade Introduction

11.4.4 Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2019-2024)

11.4.5 Sanofi-Aventis Recent Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Biosimilar of Remicade Introduction

11.5.4 Johnson & Johnson Revenue in Biosimilar of Remicade Business (2019-2024)

11.5.5 Johnson & Johnson Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Biosimilar of Remicade Introduction

11.6.4 Pfizer Revenue in Biosimilar of Remicade Business (2019-2024)

11.6.5 Pfizer Recent Developments

11.7 Novo Nordisk

11.7.1 Novo Nordisk Company Details

11.7.2 Novo Nordisk Business Overview

11.7.3 Novo Nordisk Biosimilar of Remicade Introduction

11.7.4 Novo Nordisk Revenue in Biosimilar of Remicade Business (2019-2024)

11.7.5 Novo Nordisk Recent Developments

11.8 Eli Lilly

11.8.1 Eli Lilly Company Details

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Biosimilar of Remicade Introduction

11.8.4 Eli Lilly Revenue in Biosimilar of Remicade Business (2019-2024)

11.8.5 Eli Lilly Recent Developments

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Biosimilar of Remicade Introduction

11.9.4 Novartis Revenue in Biosimilar of Remicade Business (2019-2024)

11.9.5 Novartis Recent Developments

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Biosimilar of Remicade Introduction

11.10.4 Merck Revenue in Biosimilar of Remicade Business (2019-2024)

11.10.5 Merck Recent Developments

11.11 3sbio

11.11.1 3sbio Company Details

11.11.2 3sbio Business Overview

11.11.3 3sbio Biosimilar of Remicade Introduction

11.11.4 3sbio Revenue in Biosimilar of Remicade Business (2019-2024)

11.11.5 3sbio Recent Developments

11.12 Changchun High Tech

11.12.1 Changchun High Tech Company Details

11.12.2 Changchun High Tech Business Overview

11.12.3 Changchun High Tech Biosimilar of Remicade Introduction

11.12.4 Changchun High Tech Revenue in Biosimilar of Remicade Business (2019-2024)

11.12.5 Changchun High Tech Recent Developments

11.13 CP Guojian

11.13.1 CP Guojian Company Details

11.13.2 CP Guojian Business Overview

11.13.3 CP Guojian Biosimilar of Remicade Introduction

11.13.4 CP Guojian Revenue in Biosimilar of Remicade Business (2019-2024)

11.13.5 CP Guojian Recent Developments

11.14 Biotech

11.14.1 Biotech Company Details

11.14.2 Biotech Business Overview

11.14.3 Biotech Biosimilar of Remicade Introduction

11.14.4 Biotech Revenue in Biosimilar of Remicade Business (2019-2024)

11.14.5 Biotech Recent Developments

11.15 Gelgen

11.15.1 Gelgen Company Details

11.15.2 Gelgen Business Overview

11.15.3 Gelgen Biosimilar of Remicade Introduction

11.15.4 Gelgen Revenue in Biosimilar of Remicade Business (2019-2024)

11.15.5 Gelgen Recent Developments

11.16 Innovent

11.16.1 Innovent Company Details

11.16.2 Innovent Business Overview

11.16.3 Innovent Biosimilar of Remicade Introduction

11.16.4 Innovent Revenue in Biosimilar of Remicade Business (2019-2024)

11.16.5 Innovent Recent Developments

11.17 Dong Bao

11.17.1 Dong Bao Company Details

11.17.2 Dong Bao Business Overview

11.17.3 Dong Bao Biosimilar of Remicade Introduction

11.17.4 Dong Bao Revenue in Biosimilar of Remicade Business (2019-2024)

11.17.5 Dong Bao Recent Developments

11.18 Ganlee

11.18.1 Ganlee Company Details

11.18.2 Ganlee Business Overview

11.18.3 Ganlee Biosimilar of Remicade Introduction

11.18.4 Ganlee Revenue in Biosimilar of Remicade Business (2019-2024)

11.18.5 Ganlee Recent Developments

11.19 United Laboratories

11.19.1 United Laboratories Company Details

11.19.2 United Laboratories Business Overview

11.19.3 United Laboratories Biosimilar of Remicade Introduction

11.19.4 United Laboratories Revenue in Biosimilar of Remicade Business (2019-2024)

11.19.5 United Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi Aventis

Johnson & Johnson

Pfizer Inc

Novo Nordisk

Eli Lilly

Novartis

Merck

3SBio Inc

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

List of Tables

Table 1. Global Biosimilar of Remicade Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Interferon

Table 4. Key Players of Erythropoietin

Table 5. Key Players of Insulin

Table 6. Key Players of Vaccines

Table 7. Key Players of Other

Table 8. Global Biosimilar of Remicade Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 9. Global Biosimilar of Remicade Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Biosimilar of Remicade Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Biosimilar of Remicade Market Share by Region (2019-2024)

Table 12. Global Biosimilar of Remicade Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Biosimilar of Remicade Market Share by Region (2025-2030)

Table 14. Biosimilar of Remicade Market Trends

Table 15. Biosimilar of Remicade Market Drivers

Table 16. Biosimilar of Remicade Market Challenges

Table 17. Biosimilar of Remicade Market Restraints

Table 18. Global Biosimilar of Remicade Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Biosimilar of Remicade Revenue Share by Players (2019-2024)

Table 20. Global Top Biosimilar of Remicade by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar of Remicade as of 2023)

Table 21. Global Biosimilar of Remicade Industry Ranking 2022 VS 2023 VS 2024

Table 22. Global 5 Largest Players Market Share by Biosimilar of Remicade Revenue (CR5 and HHI) & (2019-2024)

Table 23. Global Key Players of Biosimilar of Remicade, Headquarters and Area Served

Table 24. Global Key Players of Biosimilar of Remicade, Product and Application

Table 25. Global Key Players of Biosimilar of Remicade, Product and Application

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Biosimilar of Remicade Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Biosimilar of Remicade Revenue Market Share by Type (2019-2024)

Table 29. Global Biosimilar of Remicade Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Biosimilar of Remicade Revenue Market Share by Type (2025-2030)

Table 31. Global Biosimilar of Remicade Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Biosimilar of Remicade Revenue Share by Application (2019-2024)

Table 33. Global Biosimilar of Remicade Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Biosimilar of Remicade Revenue Share by Application (2025-2030)

Table 35. North America Biosimilar of Remicade Market Size by Type (2019-2024) & (US$ Million)

Table 36. North America Biosimilar of Remicade Market Size by Type (2025-2030) & (US$ Million)

Table 37. North America Biosimilar of Remicade Market Size by Application (2019-2024) & (US$ Million)

Table 38. North America Biosimilar of Remicade Market Size by Application (2025-2030) & (US$ Million)

Table 39. North America Biosimilar of Remicade Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Biosimilar of Remicade Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Biosimilar of Remicade Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Biosimilar of Remicade Market Size by Type (2019-2024) & (US$ Million)

Table 43. Europe Biosimilar of Remicade Market Size by Type (2025-2030) & (US$ Million)

Table 44. Europe Biosimilar of Remicade Market Size by Application (2019-2024) & (US$ Million)

Table 45. Europe Biosimilar of Remicade Market Size by Application (2025-2030) & (US$ Million)

Table 46. Europe Biosimilar of Remicade Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Europe Biosimilar of Remicade Market Size by Country (2019-2024) & (US$ Million)

Table 48. Europe Biosimilar of Remicade Market Size by Country (2025-2030) & (US$ Million)

Table 49. China Biosimilar of Remicade Market Size by Type (2019-2024) & (US$ Million)

Table 50. China Biosimilar of Remicade Market Size by Type (2025-2030) & (US$ Million)

Table 51. China Biosimilar of Remicade Market Size by Application (2019-2024) & (US$ Million)

Table 52. China Biosimilar of Remicade Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Biosimilar of Remicade Market Size by Type (2019-2024) & (US$ Million)

Table 54. Asia Biosimilar of Remicade Market Size by Type (2025-2030) & (US$ Million)

Table 55. Asia Biosimilar of Remicade Market Size by Application (2019-2024) & (US$ Million)

Table 56. Asia Biosimilar of Remicade Market Size by Application (2025-2030) & (US$ Million)

Table 57. Asia Biosimilar of Remicade Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 58. Asia Biosimilar of Remicade Market Size by Region (2019-2024) & (US$ Million)

Table 59. Asia Biosimilar of Remicade Market Size by Region (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Type (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Application (2025-2030) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Biosimilar of Remicade Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 65. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2019-2024) & (US$ Million)

Table 66. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size by Country (2025-2030) & (US$ Million)

Table 67. Roche Company Details

Table 68. Roche Business Overview

Table 69. Roche Biosimilar of Remicade Product

Table 70. Roche Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 71. Roche Recent Developments

Table 72. Amgen Company Details

Table 73. Amgen Business Overview

Table 74. Amgen Biosimilar of Remicade Product

Table 75. Amgen Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 76. Amgen Recent Developments

Table 77. AbbVie Company Details

Table 78. AbbVie Business Overview

Table 79. AbbVie Biosimilar of Remicade Product

Table 80. AbbVie Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 81. AbbVie Recent Developments

Table 82. Sanofi-Aventis Company Details

Table 83. Sanofi-Aventis Business Overview

Table 84. Sanofi-Aventis Biosimilar of Remicade Product

Table 85. Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 86. Sanofi-Aventis Recent Developments

Table 87. Johnson & Johnson Company Details

Table 88. Johnson & Johnson Business Overview

Table 89. Johnson & Johnson Biosimilar of Remicade Product

Table 90. Johnson & Johnson Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 91. Johnson & Johnson Recent Developments

Table 92. Pfizer Company Details

Table 93. Pfizer Business Overview

Table 94. Pfizer Biosimilar of Remicade Product

Table 95. Pfizer Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 96. Pfizer Recent Developments

Table 97. Novo Nordisk Company Details

Table 98. Novo Nordisk Business Overview

Table 99. Novo Nordisk Biosimilar of Remicade Product

Table 100. Novo Nordisk Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 101. Novo Nordisk Recent Developments

Table 102. Eli Lilly Company Details

Table 103. Eli Lilly Business Overview

Table 104. Eli Lilly Biosimilar of Remicade Product

Table 105. Eli Lilly Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 106. Eli Lilly Recent Developments

Table 107. Novartis Company Details

Table 108. Novartis Business Overview

Table 109. Novartis Biosimilar of Remicade Product

Table 110. Novartis Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 111. Novartis Recent Developments

Table 112. Merck Company Details

Table 113. Merck Business Overview

Table 114. Merck Biosimilar of Remicade Product

Table 115. Merck Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 116. Merck Recent Developments

Table 117. 3sbio Company Details

Table 118. 3sbio Business Overview

Table 119. 3sbio Biosimilar of Remicade Product

Table 120. 3sbio Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 121. 3sbio Recent Developments

Table 122. Changchun High Tech Company Details

Table 123. Changchun High Tech Business Overview

Table 124. Changchun High Tech Biosimilar of Remicade Product

Table 125. Changchun High Tech Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 126. Changchun High Tech Recent Developments

Table 127. CP Guojian Company Details

Table 128. CP Guojian Business Overview

Table 129. CP Guojian Biosimilar of Remicade Product

Table 130. CP Guojian Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 131. CP Guojian Recent Developments

Table 132. Biotech Company Details

Table 133. Biotech Business Overview

Table 134. Biotech Biosimilar of Remicade Product

Table 135. Biotech Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 136. Biotech Recent Developments

Table 137. Gelgen Company Details

Table 138. Gelgen Business Overview

Table 139. Gelgen Biosimilar of Remicade Product

Table 140. Gelgen Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 141. Gelgen Recent Developments

Table 142. Innovent Company Details

Table 143. Innovent Business Overview

Table 144. Innovent Biosimilar of Remicade Product

Table 145. Innovent Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 146. Innovent Recent Developments

Table 147. Dong Bao Company Details

Table 148. Dong Bao Business Overview

Table 149. Dong Bao Biosimilar of Remicade Product

Table 150. Dong Bao Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 151. Dong Bao Recent Developments

Table 152. Ganlee Company Details

Table 153. Ganlee Business Overview

Table 154. Ganlee Biosimilar of Remicade Product

Table 155. Ganlee Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 156. Ganlee Recent Developments

Table 157. United Laboratories Company Details

Table 158. United Laboratories Business Overview

Table 159. United Laboratories Biosimilar of Remicade Product

Table 160. United Laboratories Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 161. United Laboratories Recent Developments

Table 162. Research Programs/Design for This Report

Table 163. Key Data Information from Secondary Sources

Table 164. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biosimilar of Remicade Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Biosimilar of Remicade Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibodies Features

Figure 4. Interferon Features

Figure 5. Erythropoietin Features

Figure 6. Insulin Features

Figure 7. Vaccines Features

Figure 8. Other Features

Figure 9. Global Biosimilar of Remicade Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Biosimilar of Remicade Market Share by Application: 2023 VS 2030

Figure 11. Tumor Case Studies

Figure 12. Diabetes Case Studies

Figure 13. Cardiovascular Case Studies

Figure 14. Hemophilia Case Studies

Figure 15. Other Case Studies

Figure 16. Biosimilar of Remicade Report Years Considered

Figure 17. Global Biosimilar of Remicade Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Biosimilar of Remicade Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Biosimilar of Remicade Market Share by Region: 2023 VS 2030

Figure 20. Global Biosimilar of Remicade Market Share by Players in 2023

Figure 21. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar of Remicade as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Biosimilar of Remicade Revenue in 2023

Figure 23. North America Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Biosimilar of Remicade Market Share by Type (2019-2030)

Figure 25. North America Biosimilar of Remicade Market Share by Application (2019-2030)

Figure 26. North America Biosimilar of Remicade Market Share by Country (2019-2030)

Figure 27. United States Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Canada Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Biosimilar of Remicade Market Size YoY (2019-2030) & (US$ Million)

Figure 30. Europe Biosimilar of Remicade Market Share by Type (2019-2030)

Figure 31. Europe Biosimilar of Remicade Market Share by Application (2019-2030)

Figure 32. Europe Biosimilar of Remicade Market Share by Country (2019-2030)

Figure 33. Germany Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. France Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. U.K. Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Italy Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Russia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Nordic Countries Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. China Biosimilar of Remicade Market Size YoY (2019-2030) & (US$ Million)

Figure 40. China Biosimilar of Remicade Market Share by Type (2019-2030)

Figure 41. China Biosimilar of Remicade Market Share by Application (2019-2030)

Figure 42. Asia Biosimilar of Remicade Market Size YoY (2019-2030) & (US$ Million)

Figure 43. Asia Biosimilar of Remicade Market Share by Type (2019-2030)

Figure 44. Asia Biosimilar of Remicade Market Share by Application (2019-2030)

Figure 45. Asia Biosimilar of Remicade Market Share by Region (2019-2030)

Figure 46. Japan Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. South Korea Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. China Taiwan Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Southeast Asia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. India Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Australia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America Biosimilar of Remicade Market Size YoY (2019-2030) & (US$ Million)

Figure 53. Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Type (2019-2030)

Figure 54. Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Application (2019-2030)

Figure 55. Middle East, Africa, and Latin America Biosimilar of Remicade Market Share by Country (2019-2030)

Figure 56. Brazil Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Mexico Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Turkey Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Saudi Arabia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Israel Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 61. GCC Countries Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 62. Roche Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 63. Amgen Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 64. AbbVie Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 65. Sanofi-Aventis Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 66. Johnson & Johnson Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 67. Pfizer Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 68. Novo Nordisk Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 69. Eli Lilly Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 70. Novartis Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 71. Merck Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 72. 3sbio Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 73. Changchun High Tech Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 74. CP Guojian Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 75. Biotech Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 76. Gelgen Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 77. Innovent Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 78. Dong Bao Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 79. Ganlee Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 80. United Laboratories Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024

Biosimilar Drug Market

Global Interchangeable Biosimilars Market Research Report 2024

Remicade Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rituximab Biosimilars Market Research Report 2025

Global Biologics and Biosimilars Market Research Report 2025

Global Osteoporosis Biosimilars Market Research Report 2025

Global Innovations in Biologics and Biosimilars Market Research Report 2024

Global Tocilizumab Biosimilars Market Research Report 2024

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adalimumab Infliximab And Etanercept Biosimilars Market Research Report 2024

Bevacizumab Biosimilar Market

Global Psoriasis Biosimilar Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions